☆Pivotal bioVenture Partners Investment Advisor LLC
Quality Q
0.658
AUM ($M)
308
Positions
13
Turnover
0.20
Top-10 wt
95%
Herfindahl
0.130
History (qtrs)
6
Excess Return
—
AI Eval Run AI Eval
Holdings · 14 positions · portfolio value $308M
| Ticker | Name | Activity | Security Type | Weight | Δ Weight | Value ($M) | Shares | Δ Shares | Qtrs Held | Excess Return |
|---|---|---|---|---|---|---|---|---|---|---|
| ☆PCVX funds › | VAXCYTE INC | ADD | — | 26.9% | -1.6% | 82.9 | 1,425,470 | +53,045 | 5 | — |
| ☆ARQT funds › | ARCUTIS BIOTHERAPEUTICS INC | TRIM | — | 10.8% | -0.6% | 33.2 | 1,265,283 | -90,609 | 5 | — |
| ☆TRVI funds › | TREVI THERAPEUTICS INC | ADD | — | 10.6% | +3.9% | 32.5 | 1,742,672 | +188,946 | 5 | — |
| ☆AVLN funds › | AVALYN PHARMACEUTICALS INC | NEW | — | 10.3% | +10.3% | 31.8 | 966,792 | +966,792 | 1 | — |
| ☆EVMN funds › | EVOMMUNE INC | HOLD | — | 8.3% | -7.5% | 25.6 | 1,926,943 | +0 | 3 | — |
| ☆MPLT funds › | MAPLIGHT THERAPEUTICS INC | TRIM | — | 7.1% | +2.7% | 21.9 | 611,446 | -1 | 3 | — |
| ☆OCS funds › | OCULIS HOLDING AG | TRIM | — | 6.8% | -9.2% | 20.9 | 1,506,250 | -174,033 | 5 | — |
| ☆BIOA funds › | BIOAGE LABS INC | HOLD | — | 5.2% | +1.1% | 16.0 | 653,374 | +0 | 5 | — |
| ☆IMNM funds › | IMMUNOME INC | HOLD | — | 5.0% | -0.7% | 15.5 | 732,512 | +0 | 4 | — |
| ☆ZBIO funds › | ZENAS BIOPHARMA INC | TRIM | — | 4.0% | -0.1% | 12.5 | 490,766 | -101,225 | 5 | — |
| ☆AVTX funds › | AVALO THERAPEUTICS INC | ADD | — | 2.6% | +1.0% | 8.0 | 434,033 | +138,100 | 2 | — |
| ☆RLYB funds › | RALLYBIO CORP | HOLD | — | 1.6% | +0.6% | 4.8 | 300,579 | +0 | 2 | — |
| ☆RXRX funds › | RECURSION PHARMACEUTICALS IN | HOLD | — | 0.7% | +0.1% | 2.2 | 595,518 | +0 | 5 | — |
| ☆CUSIP:097702203 funds › | BOLT BIOTHERAPEUTICS INC | EXIT | — | 0.0% | -0.1% | 0.0 | 0 | -42,581 | 0 | — |
Point-in-time history
| Period | AUM ($M) | Positions | Turnover | Top-10 wt | Herfindahl | Quality Q | Skill | Universe |
|---|---|---|---|---|---|---|---|---|
| 2026Q2 | 308 | 13 | 0.20 | 95% | 0.130 | 0.658 | — | in |
| 2026Q1 | 280 | 13 | 0.11 | 98% | 0.158 | 0.815 | — | in |
| 2025Q4 | 259 | 12 | 0.21 | 99% | 0.148 | 0.616 | — | in |
| 2025Q3 | 173 | 10 | 0.19 | 100% | 0.206 | 0.598 | — | in |
| 2025Q2 | 161 | 12 | 0.19 | 99% | 0.197 | 0.630 | — | entered |
| 2025Q1 | 124 | 11 | 0.00 | 99% | 0.249 | 0.000 | — | out |
Long US-equity 13F disclosures only · up to 45-day reporting lag · sells = reduce/avoid, not short.
JSON: /api/signals ·
/api/funds ·
/api/status